Acadian Asset Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Buy |
46,142
+29,757
| +182% | +$133K | ﹤0.01% | 1300 |
|
|
2025
Q1 | $76K | Buy |
+16,385
| New | +$76K | ﹤0.01% | 1387 |
|
|
2024
Q4 | – | Sell |
-110,835
| Closed | -$586K | – | 1832 |
|
|
2024
Q3 | $586K | Buy |
110,835
+12,278
| +12% | +$64.9K | ﹤0.01% | 1046 |
|
|
2024
Q2 | $366K | Buy |
98,557
+43,009
| +77% | +$160K | ﹤0.01% | 1299 |
|
|
2024
Q1 | $390K | Buy |
55,548
+26,687
| +92% | +$187K | ﹤0.01% | 1064 |
|
|
2023
Q4 | $161K | Buy |
+28,861
| New | +$161K | ﹤0.01% | 1276 |
|